Increased Expression of P2RY2, CD248 and EphB1 in Gastric Cancers from Chilean Patients

AQUEA G; Bresky G; Lancellotti D.; Madariaga, JA; Zaffiri, V; Urzua, U; Haberle S; Bernal G.

Abstract

Background: Gastric cancer (GC) ranks as one of the major causes of mortality due to cancer worldwide. In Chile, it is currently the leading cause of cancer death. Identification of novel molecular markers that may help to improve disease diagnosis at early stages is imperative. Materials and Methods: Using whole-genome DNA microarrays we determined differential mRNA levels in fresh human GC samples compared to adjacent healthy mucosa from the same patients. Genes significantly overexpressed in GC were validated by RT-PCR in a group of 14 GC cases. Results: The genes CD248, NSD1, RAB17, ABCG8, Ephb1 and P2RY2 were detected as the top overexpressed in GC biopsies. P2RY2, Ephb1 and CD248 showed the best sensitivity for GC detection with values of 92.9%, 85.7% and 64.3% (p<0.05), respectively. Specificity was 85.7%, 71.4% and 71.4% (p<0.05), for each respectively.

Más información

Título según WOS: Increased Expression of P2RY2, CD248 and EphB1 in Gastric Cancers from Chilean Patients
Título según SCOPUS: Increased expression of P2RY2, CD248 and EphBl in gastric cancers from chilean patients
Título de la Revista: ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
Volumen: 15
Número: 5
Editorial: ASIAN PACIFIC ORGANIZATION CANCER PREVENTION
Fecha de publicación: 2014
Página de inicio: 1931
Página final: 1936
Idioma: English
DOI:

10.7314/APJCP.2014.15.5.1931

Notas: ISI, SCOPUS